Loading stock analysis…
Evidence Synthesis
Last synthesized: 22 Jul 2026, 14:12
Evidence Synthesis
Gangapharm reported a quarterly increase in its 53.91%, up from 2.15%.
The company's decreased from 3.59%. Gangapharm's declined from 103.3%. The company's remained flat. Gangapharm's increased from 0 shares. The company's remained steady at 12 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 53.91 % | 2.15 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 2.15 % | 3.59 | ▼ |
| REVENUE_GROWTH_YOY | 10.2 % | 103.3 | ▼ |
| PRICE_CHANGE_PERCENT | 0 % | — | - |
| DAILY_VOLUME | 8,000 shares | 0 | ▲ |
| CLOSE_PRICE | 12 INR | 12 | - |